Medicare Enrolled
Dr. Steven Regwan, D.O.
Cardiovascular Disease · Salinas, CA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Regwan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Regwan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Regwan
Dr. Steven Regwan is a cardiovascular disease specialist in Salinas, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Regwan performed 4,945 Medicare services across 3,158 unique beneficiaries.
Between the years covered by Open Payments, Dr. Regwan received a total of $157,825 from 44 pharmaceutical and/or device companies across 1330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Regwan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 19% volume in CA
$157,825 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,945
Medicare services
Top 19% in CA for cardiovascular disease
3,158
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~275 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,024 | $98 | $250 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
493 | $56 | $214 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
424 | $18 | $90 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
376 | $22 | $88 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
292 | $64 | $240 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
266 | $19 | $74 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
266 | $44 | $76 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
238 | $11 | $51 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
218 | $12 | $40 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
174 | $4 | $21 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
123 | $10 | $139 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
117 | $6 | $22 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
110 | $115 | $382 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
64 | $99 | $248 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
63 | $62 | $173 |
| Cardiac catheterization | 56 | $229 | $773 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
56 | $140 | $475 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
53 | $64 | $167 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
50 | $26 | $176 |
| Transesophageal echocardiogram during heart surgery An ultrasound of the heart performed using a probe inserted into the esophagus while surgery on the heart or major blood vessels is taking place, including a written report. |
43 | $186 | $595 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
36 | $3 | $44 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
35 | $60 | $275 |
| Pacemaker insertion with heart chamber electrodes A surgical procedure to implant a pacemaker device and place electrodes into the upper and lower chambers of the heart to regulate heart rhythm. |
33 | $424 | $1,359 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
32 | $84 | $344 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $138 | $336 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
26 | $21 | $106 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
24 | $11 | $43 |
| New patient office visit, complex (60-74 min) | 23 | $181 | $480 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
22 | $21 | $72 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
21 | $11 | $43 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
21 | $17 | $66 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $94 | $323 |
| Insertion of implantable heart rhythm monitor A small device is placed under the skin to continuously record the heart's electrical activity. This helps detect irregular heart rhythms that may not appear during a standard office visit. |
19 | $58 | $14,345 |
| Heart muscle strain imaging | 18 | $10 | $105 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $54 | $167 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
14 | $5 | $28 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
14 | $42 | $104 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 14 | $286 | $1,003 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
12 | $53 | $238 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
11 | $14 | $63 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.3% high complexity
12.8% medium
56.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$157,825
Total received (2018-2024)
Avg $22,546/year across 7 years
Top 5% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
1,330
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$130,939 (83.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,102 (14.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,783 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$16,126
2023
$6,991
2022
$2,702
2021
$7,559
2020
$7,731
2019
$67,228
2018
$49,487
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$9,995
Abbott Laboratories
$3,234
Medtronic, Inc.
$649
Novartis Pharmaceuticals Corporation
$332
Novo Nordisk Inc
$329
E.R. Squibb & Sons, L.L.C.
$281
Boston Scientific Corporation
$240
Amgen Inc.
$128
Mylan Specialty L.P.
$124
Philips North America LLC
$118
Merck Sharp & Dohme LLC
$90
Janssen Pharmaceuticals, Inc
$70
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$68
Edwards Lifesciences Corporation
$68
Baxter Healthcare
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
PFIZER INC.
$59
iRhythm Technologies, Inc.
$58
Bayer Healthcare Pharmaceuticals Inc.
$40
CARDIVA MEDICAL, INC.
$36
Inari Medical, Inc.
$29
Kiniksa Pharmaceuticals International, plc
$22
ATRICURE, INC.
$17
BIOTRONIK INC.
$15
Top 3 companies account for 86.1% of 2024 payments
All-time payments by company (2018-2024) ›
Relypsa, Inc.
$114,503
Abbott Laboratories
$13,009
AstraZeneca Pharmaceuticals LP
$10,268
Vifor Pharma, Inc.
$6,330
Medtronic, Inc.
$4,182
Medtronic Vascular, Inc.
$2,035
Boston Scientific Corporation
$1,239
Novartis Pharmaceuticals Corporation
$863
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$649
E.R. Squibb & Sons, L.L.C.
$579
PFIZER INC.
$528
Janssen Pharmaceuticals, Inc
$427
Novo Nordisk Inc
$357
Amgen Inc.
$316
Boehringer Ingelheim Pharmaceuticals, Inc.
$293
Merck Sharp & Dohme LLC
$268
Philips Electronics North America Corporation
$186
BOSTON SCIENTIFIC CORPORATION
$171
HeartFlow, Inc.
$148
Alnylam Pharmaceuticals Inc.
$144
Mylan Specialty L.P.
$124
Philips North America LLC
$118
Regeneron Healthcare Solutions, Inc.
$115
Edwards Lifesciences Corporation
$103
SANOFI-AVENTIS U.S. LLC
$90
Lundbeck LLC
$79
Baxter Healthcare
$64
Inari Medical, Inc.
$64
CARDIVA MEDICAL, INC.
$61
iRhythm Technologies, Inc.
$58
ARBOR PHARMACEUTICALS, INC.
$58
Kowa Pharmaceuticals America, Inc.
$57
LivaNova USA, Inc.
$55
Kestra Medical Technology Services, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$40
Otsuka America Pharmaceutical, Inc.
$39
BIOTRONIK INC.
$28
Gilead Sciences, Inc.
$27
GENZYME CORPORATION
$22
Kiniksa Pharmaceuticals International, plc
$22
Kiniksa Pharmaceuticals, Ltd.
$21
ATRICURE, INC.
$17
Daiichi Sankyo Inc.
$15
Bardy Diagnostics, Inc.
$9
Top 3 companies account for 87.3% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (5050) Ext Holter · ABRE · ACCENT · ACCOLADE · ACCOLADE SR · ADAPTA · AMPLATZER TALISMAN · AMVIA EDGE · ASSURITY · ATRICLIP LAA EXCLUSION SYSTEM · AURORA EV-ICD MRI SURESCAN · AVEIR · AZURE XT DR MRI SURESCAN · Advisa · Aimovig · Arcalyst · Assure WCD · Assurity Pacemaker · Attain · Azure · BRILINTA · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CLARIA MRI QUAD CRT-D SURESCAN · COBALT DR MRI SURESCAN · CONFIRM RX · COREVALVE EVOLUT R · CRT-Ds · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Claria MRI · Cobalt · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · ELIQUIS · ENTRESTO · EP-NurseMate Remote Station · EVKEEZA · Edarbyclor · Edora 8 DR-T · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · Evera · FABRAZYME · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FORTIFY ASSURA · Fortify Assura · GALLANT · Hillrom - Carnation Ambulatory Monitor · IN.PACT ADMIRAL · INJECTAFER · JARDIANCE · JOT DX · Kerendia · LEQVIO · LINQ II · LOKELMA · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MICRA · MITRACLIP · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · Mitra Clip system · MitraClip System · NORTHERA · ONPATTRO · Ozempic · PASCAL · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Percepta · Performa · QUADRA ASSURA · QUARTET · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · Repatha · Reveal LINQ · Rybelsus · S · SAMSCA · SAPIEN 3 Ultra RESILIA · SAVVYWIRE · SYMPLICITY G3 · Tandem Heart kit · Tandem Life - ProtekDuo kit · VERQUVO · VYNDAQEL · Veltassa · Visia AF · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · YUPELRI · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (83%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
25
Per 100K population
5.7
County median income
$94,486
Nearest hospital
SALINAS VALLEY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Regwan is a remote & electrophysiology specialist, with above-average Medicare volume (top 19% in CA), with speaking/promotional industry engagement in the top 5% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Regwan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Regwan performed 1,024 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Regwan receive payments from pharmaceutical companies?
Yes. Dr. Regwan received a total of $157,825 from 44 companies across 1,330 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Regwan's costs compare to other cardiologists in Salinas?
Dr. Regwan's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Regwan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Salinas
Browse cardiologists in Salinas ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Relypsa, Inc. Payments to Doctors
See all physicians who received payments from Relypsa, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology